385 related articles for article (PubMed ID: 11547834)
1. Tibolone exerts its protective effect on trabecular bone loss through the estrogen receptor.
Ederveen AG; Kloosterboer HJ
J Bone Miner Res; 2001 Sep; 16(9):1651-7. PubMed ID: 11547834
[TBL] [Abstract][Full Text] [Related]
2. Effect of 16 months of treatment with tibolone on bone mass, turnover, and biomechanical quality in mature ovariectomized rats.
Ederveen AG; Spanjers CP; Quaijtaal JH; Kloosterboer HJ
J Bone Miner Res; 2001 Sep; 16(9):1674-81. PubMed ID: 11547837
[TBL] [Abstract][Full Text] [Related]
3. Tibolone, a steroid with a tissue-specific hormonal profile, completely prevents ovariectomy-induced bone loss in sexually mature rats.
Ederveen AG; Kloosterboer HJ
J Bone Miner Res; 1999 Nov; 14(11):1963-70. PubMed ID: 10571697
[TBL] [Abstract][Full Text] [Related]
4. Skeletal effects of parathyroid hormone infusion in ovariectomized rats with or without estrogen repletion.
Shen V; Birchman R; Wu DD; Lindsay R
J Bone Miner Res; 2000 Apr; 15(4):740-6. PubMed ID: 10780865
[TBL] [Abstract][Full Text] [Related]
5. Effects of tibolone (Org OD14) treatment for 3 months on ovariectomy-induced osteopenia in 8-month-old rats on a low-calcium diet: preventive testing for 3 months.
Kasugai Y; Ikegami A; Matsuo K; Ohashi M; Sukamoto T; Hosoi T; Ouchi Y; Orimo H
Bone; 1998 Feb; 22(2):119-24. PubMed ID: 9477234
[TBL] [Abstract][Full Text] [Related]
6. Effects of 16 weeks of treatment with tibolone on bone mass and bone mechanical and histomorphometric indices in mature ovariectomized rats with established osteopenia on a low-calcium diet.
Yoshitake K; Yokota K; Kasugai Y; Kagawa M; Sukamoto T; Nakamura T
Bone; 1999 Sep; 25(3):311-9. PubMed ID: 10495135
[TBL] [Abstract][Full Text] [Related]
7. Effects of tibolone on the development of osteopenia induced by ovariectomy in rats.
Pytlik M
Pol J Pharmacol; 2002; 54(1):35-43. PubMed ID: 12020042
[TBL] [Abstract][Full Text] [Related]
8. Tibolone and its effects on bone: a review.
Berning B; Bennink HJ; Fauser BC
Climacteric; 2001 Jun; 4(2):120-36. PubMed ID: 11428176
[TBL] [Abstract][Full Text] [Related]
9. Both hPTH(1-34) and bFGF increase trabecular bone mass in osteopenic rats but they have different effects on trabecular bone architecture.
Lane NE; Yao W; Kinney JH; Modin G; Balooch M; Wronski TJ
J Bone Miner Res; 2003 Dec; 18(12):2105-15. PubMed ID: 14672345
[TBL] [Abstract][Full Text] [Related]
10. Clodronate prevents osteopenia and loss of trabecular connectivity in estrogen-deficient rats.
Kippo K; Hannuniemi R; Isaksson P; Laurén L; Osterman T; Peng Z; Tuukkanen J; Kuurtamo P; Väänänen HK; Sellman R
J Bone Miner Res; 1998 Feb; 13(2):287-96. PubMed ID: 9495523
[TBL] [Abstract][Full Text] [Related]
11. Daily treatment of aged ovariectomized rats with human parathyroid hormone (1-84) for 12 months reverses bone loss and enhances trabecular and cortical bone strength.
Fox J; Miller MA; Newman MK; Metcalfe AF; Turner CH; Recker RR; Smith SY
Calcif Tissue Int; 2006 Oct; 79(4):262-72. PubMed ID: 16969596
[TBL] [Abstract][Full Text] [Related]
12. Additive protective effects of estrogen and androgen treatment on trabecular bone in ovariectomized rats.
Tivesten A; Movérare-Skrtic S; Chagin A; Venken K; Salmon P; Vanderschueren D; Sävendahl L; Holmäng A; Ohlsson C
J Bone Miner Res; 2004 Nov; 19(11):1833-9. PubMed ID: 15476584
[TBL] [Abstract][Full Text] [Related]
13. Protective effects of sodium daidzein sulfonate on trabecular bone in ovariectomized rats.
Ren P; Ji H; Shao Q; Chen X; Han J; Sun Y
Pharmacology; 2007; 79(3):129-36. PubMed ID: 17179740
[TBL] [Abstract][Full Text] [Related]
14. Raloxifene and vitamin K2 combine to improve the femoral neck strength of ovariectomized rats.
Iwamoto J; Yeh JK; Schmidt A; Rowley E; Stanfield L; Takeda T; Sato M
Calcif Tissue Int; 2005 Aug; 77(2):119-26. PubMed ID: 16059775
[TBL] [Abstract][Full Text] [Related]
15. Effects of estrogen and tibolone on bladder histology and estrogen receptors in rats.
Yang X; Li YZ; Mao Z; Gu P; Shang M
Chin Med J (Engl); 2009 Feb; 122(4):381-5. PubMed ID: 19302740
[TBL] [Abstract][Full Text] [Related]
16. Effects of recombinant human growth hormone and insulin-like growth factor-I, with or without 17 beta-estradiol, on bone and mineral homeostasis of aged ovariectomized rats.
Verhaeghe J; van Bree R; Van Herck E; Thomas H; Skottner A; Dequeker J; Mosekilde L; Einhorn TA; Bouillon R
J Bone Miner Res; 1996 Nov; 11(11):1723-35. PubMed ID: 8915780
[TBL] [Abstract][Full Text] [Related]
17. A new synthetic steroid, osaterone acetate (TZP-4238), increases cortical bone mass and strength by enhancing bone formation in ovariectomized rats.
Fuse H; Fukumoto S; Sone H; Miyata Y; Saito T; Nakayama K; Takahashi H; Matsumoto T; Ogata E
J Bone Miner Res; 1997 Apr; 12(4):590-7. PubMed ID: 9101370
[TBL] [Abstract][Full Text] [Related]
18. Long-term protective effects of zoledronic acid on cancellous and cortical bone in the ovariectomized rat.
Gasser JA; Ingold P; Venturiere A; Shen V; Green JR
J Bone Miner Res; 2008 Apr; 23(4):544-51. PubMed ID: 18072878
[TBL] [Abstract][Full Text] [Related]
19. A new selective estrogen receptor modulator, CHF 4227.01, preserves bone mass and microarchitecture in ovariectomized rats.
Armamento-Villareal R; Sheikh S; Nawaz A; Napoli N; Mueller C; Halstead LR; Brodt MD; Silva MJ; Galbiati E; Caruso PL; Civelli M; Civitelli R
J Bone Miner Res; 2005 Dec; 20(12):2178-88. PubMed ID: 16294271
[TBL] [Abstract][Full Text] [Related]
20. Long-term minodronic acid (ONO-5920/YM529) treatment suppresses increased bone turnover, plus prevents reduction in bone mass and bone strength in ovariectomized rats with established osteopenia.
Tanaka M; Mori H; Kayasuga R; Ochi Y; Kawada N; Yamada H; Kishikawa K
Bone; 2008 Nov; 43(5):894-900. PubMed ID: 18687415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
